Effector-mediated eradication of precursor B acute lymphoblastic leukemia with a novel Fc-engineered monoclonal antibody targeting the BAFF-R.
about
B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related CachexiaProphylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation.Cytotoxicity of CD56-positive lymphocytes against autologous B-cell precursor acute lymphoblastic leukemia cellsPotential of autologous NK cell therapy to eradicate leukemia: "Education is [not] the best provision for old age" -AristotleEngineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia.
P2860
Effector-mediated eradication of precursor B acute lymphoblastic leukemia with a novel Fc-engineered monoclonal antibody targeting the BAFF-R.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Effector-mediated eradication ...... antibody targeting the BAFF-R.
@en
type
label
Effector-mediated eradication ...... antibody targeting the BAFF-R.
@en
prefLabel
Effector-mediated eradication ...... antibody targeting the BAFF-R.
@en
P2093
P2860
P1476
Effector-mediated eradication ...... antibody targeting the BAFF-R.
@en
P2093
Anna Arutyunyan
Heather Huet
Hermann Gram
Hisham Abdel-Azim
Isabelle Schiffer
John Groffen
Margaret E McLaughlin
Nora Heisterkamp
P2860
P304
P356
10.1158/1535-7163.MCT-13-1023
P577
2014-05-13T00:00:00Z